27,204 HIMS shares to be sold under Form 144 (NYSE: HIMS)

Rhea-AI Filing Summary

Form 144 indicates a planned sale of 27,204 shares of HIMS common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $828,905.88. These shares relate to stock options granted as compensation and acquired via cashless exercise and same-day sale transactions dated 02/24/2022 and 03/01/2023.

The notice lists 219,270,891 common shares outstanding and details prior sales by Oluyemi Okupe over the past three months, including multiple blocks of common stock sold on 11/17/2025, 12/22/2025, and 01/05/2026 with specified share amounts and gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	27204	828905.88	219270891	01/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/24/2022	Acquired as compensation -- Stock Options	Issuer			21954	02/24/2022	Compensation -- Cashless exercise / same-day sale
Common	03/01/2023	Acquired as compensation -- Stock Options	Issuer			5250	03/01/2023	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	3808	128984.58
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	11/17/2025	1543	56773.3
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	12/22/2025	6926	248014.52
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	11/17/2025	7615	281657.53
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	772	26093.6
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	4490	151374.06
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	12/22/2025	4618	164491.31
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	11/17/2025	14029	515060.71
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	12/22/2025	11546	412204.9

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares are covered by this Form 144 filing?

The Form 144 covers a planned sale of 27,204 shares of common stock of HIMS, with an aggregate market value of $828,905.88 as disclosed in the securities information section.

Which broker and exchange are involved in this HIMS Form 144 sale?

The planned sale of HIMS common stock is listed through Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282, and the securities are to be sold on the NYSE.

How were the HIMS shares in this Form 144 acquired?

The common shares were acquired as compensation via stock options from the issuer on 02/24/2022 (21,954 securities) and 03/01/2023 (5,250 securities), with the nature of payment described as compensation through cashless exercise and same-day sale.

How many HIMS shares are outstanding according to this filing?

The securities information section states that the number of common shares outstanding is 219,270,891 at the time referenced in the Form 144.

What prior HIMS stock sales are disclosed for the past three months?

The filing lists several prior sales of HIMS common stock by Oluyemi Okupe over the past three months, including transactions on 11/17/2025, 12/22/2025, and 01/05/2026, each with specified share amounts and gross proceeds such as 14,029 shares for $515,060.71 on 11/17/2025.

What representation does the seller make in this HIMS Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current and prospective operations that has not been publicly disclosed, as stated in the remarks and signature section.